BE857535A - Nouvelles organoprostaglandines et medicament les contenant - Google Patents

Nouvelles organoprostaglandines et medicament les contenant

Info

Publication number
BE857535A
BE857535A BE179948A BE179948A BE857535A BE 857535 A BE857535 A BE 857535A BE 179948 A BE179948 A BE 179948A BE 179948 A BE179948 A BE 179948A BE 857535 A BE857535 A BE 857535A
Authority
BE
Belgium
Prior art keywords
organoprostaglandins
new
products containing
medicinal products
medicinal
Prior art date
Application number
BE179948A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BE857535A publication Critical patent/BE857535A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE179948A 1976-08-06 1977-08-05 Nouvelles organoprostaglandines et medicament les contenant BE857535A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/712,361 US4045465A (en) 1976-08-06 1976-08-06 Cyanoprostaglandins

Publications (1)

Publication Number Publication Date
BE857535A true BE857535A (fr) 1978-02-06

Family

ID=24861791

Family Applications (1)

Application Number Title Priority Date Filing Date
BE179948A BE857535A (fr) 1976-08-06 1977-08-05 Nouvelles organoprostaglandines et medicament les contenant

Country Status (15)

Country Link
US (3) US4045465A (fr)
JP (1) JPS5321121A (fr)
BE (1) BE857535A (fr)
DE (1) DE2733976A1 (fr)
DK (1) DK345677A (fr)
ES (1) ES461200A1 (fr)
FI (1) FI772328A (fr)
FR (1) FR2372156B1 (fr)
GB (1) GB1553556A (fr)
IE (1) IE45549B1 (fr)
IL (1) IL52562A0 (fr)
LU (1) LU77928A1 (fr)
NL (1) NL169312C (fr)
PT (1) PT66862B (fr)
SE (1) SE7708124L (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4125556A (en) * 1977-05-19 1978-11-14 The Dow Chemical Company Synthesis of 11-deoxyprostaglandins
DE2733680A1 (de) * 1977-07-26 1979-02-08 Bayer Ag Neue prostaglandin-analoga und verfahren zu ihrer herstellung
JPH02500956A (ja) * 1986-11-21 1990-04-05 サンタ・バーバラ・リサーチ・センター パウダ放射装置
JP6145356B2 (ja) * 2013-08-07 2017-06-07 矢崎総業株式会社 電線保護部材

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723423A (en) * 1971-01-22 1973-03-27 Alza Corp Novel alkoxytetrahydropyranol ethers of prostaglandins
US3853854A (en) * 1971-06-24 1974-12-10 Alza Corp Novel 5{40 ,6{40 -dihydro-2h-pyran-4{40 -yl prostaglandin ethers
US3870747A (en) * 1971-11-24 1975-03-11 Merck & Co Inc Intermediates and process for prostaglandin synthesis
BE795589A (fr) * 1972-02-18 1973-08-16 May & Baker Ltd Derives du cyclopentane
US3890351A (en) * 1972-05-08 1975-06-17 Merck & Co Inc Loweralkyl esters of 3{62 -{8 tri(lower alkyl)silyloxy{9 -2{60 -(3-oxo or hydroxy-1-octenyl)-5-oxo-1{62 -cyclopentane-heptanoic acid, 5-cyclic ethylene acetal

Also Published As

Publication number Publication date
FI772328A (fr) 1978-02-07
DK345677A (da) 1978-02-07
ES461200A1 (es) 1978-05-01
US4045465A (en) 1977-08-30
JPS5757032B2 (fr) 1982-12-02
SE7708124L (sv) 1978-02-07
NL7708471A (nl) 1978-02-08
DE2733976A1 (de) 1978-02-09
IL52562A0 (en) 1977-10-31
NL169312B (nl) 1982-02-01
US4078021A (en) 1978-03-07
NL169312C (nl) 1982-07-01
PT66862A (en) 1977-08-01
FR2372156A1 (fr) 1978-06-23
PT66862B (en) 1978-12-29
GB1553556A (en) 1979-09-26
IE45549L (en) 1978-02-06
US4074044A (en) 1978-02-14
JPS5321121A (en) 1978-02-27
FR2372156B1 (fr) 1984-04-06
IE45549B1 (en) 1982-09-22
LU77928A1 (fr) 1979-05-23

Similar Documents

Publication Publication Date Title
BE871907A (fr) Nouveaux 1,9-dihydroxyoctahydrophenanthrenes et medicament les contenant
BE846335R (fr) (polyalcoxy-phenyl)-4-pyrrolidinones-2 et medicaments qui en contiennent
BE860877A (fr) Spirolactones steroidiques et medicaments qui en contiennent
FR2279406A1 (fr) Nouveaux derives de quinazoline et medicament les contenant
FR2295739A1 (fr) Oxo-20 homopregnanes et medicaments qui en contiennent
FR2281123A1 (fr) Oxo-20 pregnanes et medicaments qui en contiennent
BE849788A (fr) Ethers d'imidazolyl-oximes et medicaments qui en contiennent
BE843505A (fr) Pyrrolidones et medicaments qui en contiennent
BE869166A (fr) Nouvelles 4-pyrones substituees en positions 2, 3 et 6 et medicament les contenant
FR2342990A1 (fr) Androstenones et medicaments qui en contiennent
BE858147A (fr) Nouvelles heterocyclo-omega-pentanorprostaglandines aryliques substituees en position 2 et medicament les contenant
FR2342973A1 (fr) Azapurines et medicaments contenant ces substances
FR2343477A1 (fr) Nouvelles phenylpyridylhydantoines substituees et medicament les contenant
BE849346R (fr) Pyrrolidones et medicaments qui en contiennent
BE857535A (fr) Nouvelles organoprostaglandines et medicament les contenant
FR2281766A1 (fr) Oestratetraenes et medicament contenant ces substances
FR2343482A1 (fr) La 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-seryl-d-isoglutamine et medicaments la contenant
FR2316941A1 (fr) Pyrrolidones et medicaments qui en contiennent
FR2347925A1 (fr) Medicaments, cosmetiques et pesticides renfermant des fluoroacyl-resorcines
FR2314724A1 (fr) Medicament anticonvulsif contenant un diphenylsilane
FR2291758A1 (fr) Nouvelles benzodiazepines, leur preparation et medicament les contenant
FR2334369A1 (fr) Nouveaux nonapeptides et medicament les contenant
FR2340319A1 (fr) Nouvelles triazinobenzodiazepines, leur preparation et medicament les contenant
BE824443A (fr) Thienyl-carboxylates de papaverine et medicaments les contenant
BE873043A (fr) Nouvelles cycloalcenochromes et medicament les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: PFIZER INC.

Effective date: 19850831